KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash & Current Investments (2016 - 2025)

Edwards Lifesciences has reported Cash & Current Investments over the past 17 years, most recently at $4.2 billion for Q4 2025.

  • Quarterly results put Cash & Current Investments at $4.2 billion for Q4 2025, up 6.3% from a year ago — trailing twelve months through Dec 2025 was $4.2 billion (up 6.3% YoY), and the annual figure for FY2025 was $4.2 billion, up 6.3%.
  • Cash & Current Investments for Q4 2025 was $4.2 billion at Edwards Lifesciences, up from $3.8 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for EW hit a ceiling of $4.4 billion in Q3 2024 and a floor of $512.2 million in Q4 2023.
  • Median Cash & Current Investments over the past 5 years was $1.7 billion (2022), compared with a mean of $2.3 billion.
  • Biggest five-year swings in Cash & Current Investments: crashed 57.59% in 2023 and later surged 676.24% in 2024.
  • Edwards Lifesciences' Cash & Current Investments stood at $1.5 billion in 2021, then fell by 17.66% to $1.2 billion in 2022, then crashed by 57.59% to $512.2 million in 2023, then surged by 676.24% to $4.0 billion in 2024, then grew by 6.3% to $4.2 billion in 2025.
  • The last three reported values for Cash & Current Investments were $4.2 billion (Q4 2025), $3.8 billion (Q3 2025), and $4.1 billion (Q2 2025) per Business Quant data.